German Society for Hematology and Medical Oncology eV / Deutsche Gesellschaft fur Hamatologie und Medizinische Onkologie (DGHO)

Summary

The DGHO German Society for Hematology and Medical Oncology eV is an association of physicians, scientists and interested persons who specialize in the research, diagnosis and treatment of blood diseases and malignant solid tumors. The DGHO currently has more than 3,400 members in one of the most innovative and research-intensive medical disciplines.

The German Hematological Society was founded in 1937. The field has seen a boom in the increasingly successful use of drugs to treat malignant diseases such as leukemia and lymphoma since the 1970s. These experiences expanded the field of activity to the drug therapy of solid tumors and led to the current name DGHO German Society for Hematology and Medical Oncology eV.

The research and treatment of malignant diseases is a major focus of the professional society. The spectrum of activities ranges from basic research to the development of new drugs for clinical trials, the promotion of networks and health services research. However, non-malignant haematological diseases, blood clotting disorders, laboratory analyzes, the entire range of supportive and palliative care for patients, care and ethical aspects also play a key role in the DGHO. In more than 30 topic-centered working groups, the members are committed to the further development of hematology and medical oncology.